The board of directors of Teamway International Group Holdings Limited (the Company, together with its subsidiaries, the Group) is pleased to announces that Mr. Lee Hung Yuen (Mr. Lee) will be appointed as a non-executive director and Mr. Chow Wai Hung Enzo (Mr. Chow) will be appointed as an independent non-executive director with effect from 3 January 2024. The biographical details of Mr. Lee and Mr. Chow are set out below: Mr. Lee, aged 53, has over 25 years of experiences in business development and investment in China. He has been engaged in the manufacture and sale of electronic light-emitting diode lighting products since 1995.

Mr. Lee has been a director of Jiangxi Province Yifeng Wanguo Mining Company Limited since November 2007, a company incorporated in PRC which conducts underground mining of non-ferrous polymetallic mineral resources in Jiangxi Province in PRC. Mr. Lee is currently the managing director of Longmax Holding (HK) Limited since 2006, a private company engaging in investment in the manufacturing field. Mr. Lee was a non-executive director of Goldstone Capital Group Limited (stock code: 1160) from 8 December 2021 to 11 October 2022 and a non-executive director of Wanguo International Mining Group Limited (stock code: 3939) from 12 June 2012 to 29 September 2021.

Mr. Chow, aged 49, graduated from the City University of Hong Kong in 1997 with a Bachelor of Laws (Hons) degree and received Postgraduate Certificate in Laws in 1998. Having received professional training for 2 years, Mr. Chow was admitted as a solicitor of the High Court of the Hong Kong Special Administrative Region (HKSAR) in 2000. Mr. Chow worked as a Government Counsel in the Department of Justice, Government of the HKSAR between 2000 and 2005, handling amongst others land and town planning disputes and related judicial review cases concerning the HKSAR Government.

He was admitted as a barrister-at-law of the HKSAR in 2006 and since then has been in private practice, focusing on civil litigation, until now. Mr. Chow was appointed by the Judiciary of the HKSAR as a Deputy District Judge for the period from 4 October 2021 to 22 October 2021. In the meantime, he is currently a Legal Advisor to the Chinese Medicine Council of Hong Kong.

Mr. Chow (i) has not held any directorships in any public companies listed in Hong Kong or other major exchanges in the past three years; (ii) did not have or was not deemed to have any interest or short position (within the meaning of Part XV of the SFO) in any shares, underlying shares or debentures of the Company or its associated corporations; (iii) did not have any relationship with any Director, senior management, substantial shareholder or controlling shareholder of the Company; and (iv) did not hold other positions within the Group. There is no other information in relation to the appointment of Mr. Chow that is required to be disclosed pursuant to Rule 13.51(2)(h) to (v) of Listing Rules and there is no other matter in relation to the appointment of Mr. Chow that needs to be brought to the attention of the shareholders of the Company. The Board announces that Mr. Chow will be appointed as the chairman of the nomination committee, a member of each of the audit committee and the Remuneration Committee of the Company with effect from 3 January 2024.

The Board welcomes Mr. Lee and Mr. Chow for joining the Board.